Apollo

News

Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptives products.

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.